Formulations for tyrosine kinase inhibitors

Details for Australian Patent Application No. 2004225949 (hide)

International Classifications

Event Publications

6 October 2005 PCT application entered the National Phase

PCT publication WO2004/087651 Priority application(s): WO2004/087651

17 November 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Merck & Co. Inc. to Merck & Co., Inc.

2 November 2006 Application Accepted

Published as AU-B-2004225949

1 March 2007 Standard Patent Sealed

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.